HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

S Noguchi Selected Research

Epirubicin (Ellence)

12/2012Clinicopathological analysis of GATA3-positive breast cancers with special reference to response to neoadjuvant chemotherapy.
4/2012Recurrence risk score based on the specific activity of CDK1 and CDK2 predicts response to neoadjuvant paclitaxel followed by 5-fluorouracil, epirubicin and cyclophosphamide in breast cancers.
2/2011Prognostic significance of Ki67 index after neoadjuvant chemotherapy in breast cancer.
7/2001Prediction of chemotherapeutic response by Technetium 99m--MIBI scintigraphy in breast carcinoma patients.
4/2001[Study of neoadjuvant chemotherapy for invasive bladder cancer with MEC (methotrexate, epirubicin, cisplatin) therapy].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


S Noguchi Research Topics

Disease

37Breast Neoplasms (Breast Cancer)
12/2014 - 01/2000
34Neoplasms (Cancer)
06/2018 - 04/2000
6Muscular Dystrophies (Muscular Dystrophy)
09/2007 - 04/2000
5Graves Disease (Basedow Disease)
04/2006 - 04/2000
4Carcinoma (Carcinomatosis)
11/2019 - 04/2000
4Melanoma (Melanoma, Malignant)
03/2018 - 12/2012
4Neoplasm Micrometastasis
05/2001 - 05/2000
4Vitamin D Deficiency
04/2001 - 04/2000
3Urinary Bladder Neoplasms (Bladder Cancer)
02/2013 - 08/2000
3Muscular Diseases (Myopathy)
03/2012 - 06/2004
3Papillary Carcinoma
01/2005 - 10/2000
3Carcinogenesis
05/2001 - 12/2000
3Tetany (Spasmophilia)
04/2001 - 04/2000
2Disease Progression
12/2010 - 01/2006
2Nonaka type Distal myopathy
12/2007 - 10/2005
2Scleroatonic muscular dystrophy
09/2007 - 02/2004
2Lymphatic Metastasis
06/2001 - 05/2001
2Virus Diseases (Viral Diseases)
05/2001 - 10/2000
2Secondary Hyperparathyroidism
04/2001 - 04/2000
2Hypoparathyroidism
04/2001 - 04/2000
2Prostatic Neoplasms (Prostate Cancer)
03/2001 - 12/2000
2Sarcoglycanopathies
02/2001 - 04/2000
2Infections
12/2000 - 07/2000
2Transitional Cell Carcinoma
04/2000 - 03/2000
1BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
03/2018
1Periodontitis
02/2017
1Choriocarcinoma
08/2014
1Hyperglycemia
04/2014
1Pneumonia (Pneumonitis)
04/2014

Drug/Important Bio-Agent (IBA)

11Messenger RNA (mRNA)IBA
08/2014 - 09/2000
9Proteins (Proteins, Gene)FDA Link
03/2018 - 10/2000
9Estrogen ReceptorsIBA
12/2012 - 10/2000
6Biological ProductsIBA
12/2016 - 03/2001
6Progesterone Receptors (Progesterone Receptor)IBA
12/2012 - 10/2000
6CalciumIBA
10/2005 - 04/2000
5Estrogens (Estrogen)FDA Link
08/2014 - 10/2000
5Paclitaxel (Taxol)FDA LinkGeneric
12/2012 - 07/2008
5Epirubicin (Ellence)FDA LinkGeneric
12/2012 - 04/2001
4Hormones (Hormone)IBA
12/2014 - 12/2000
4DNA (Deoxyribonucleic Acid)IBA
01/2014 - 10/2000
4Cyclophosphamide (Cytoxan)FDA LinkGeneric
12/2012 - 07/2001
4Docetaxel (Taxotere)FDA Link
01/2012 - 07/2001
4Coloring Agents (Dyes)IBA
08/2002 - 05/2000
4Estrogen Receptor alphaIBA
09/2001 - 10/2000
4hydroxide ionIBA
04/2001 - 04/2000
3MicroRNAs (MicroRNA)IBA
12/2016 - 02/2013
3Member 1 Subfamily B ATP Binding Cassette TransporterIBA
02/2011 - 07/2001
3EnzymesIBA
12/2007 - 10/2000
3CollagenIBA
09/2007 - 02/2004
3Sarcoglycans (beta Sarcoglycan)IBA
01/2006 - 04/2000
3Aromatase (CYP19)IBA
11/2003 - 07/2000
3RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA
09/2001 - 09/2000
3Parathyroid Hormone (Parathormone)IBA
04/2001 - 04/2000
3Vitamin DFDA LinkGeneric
04/2001 - 04/2000
2Phenobarbital (Luminal)FDA Link
11/2019 - 12/2012
2Carrier Proteins (Binding Protein)IBA
12/2016 - 12/2012
2Epidermal Growth Factor (EGF)IBA
12/2014 - 05/2001
2EverolimusFDA Link
12/2014 - 04/2014
2exemestane (Aromasin)FDA Link
12/2014 - 04/2014
2Fluorouracil (Carac)FDA LinkGeneric
12/2012 - 04/2012
2Cyclin-Dependent Kinases (cdk Proteins)IBA
02/2009 - 01/2008
2Taxoids (Taxanes)IBA
07/2008 - 07/2001
2Advanced Glycation End ProductsIBA
02/2006 - 09/2004
2Biomarkers (Surrogate Marker)IBA
01/2006 - 07/2001
2Phosphotransferases (Kinase)IBA
10/2005 - 05/2001
2Radioisotopes (Radionuclides)IBA
08/2002 - 02/2001
2Eosine Yellowish-(YS) (Eosin)IBA
08/2002 - 05/2000
2Technetium Tc 99m Sestamibi (Cardiolite)FDA LinkGeneric
12/2001 - 06/2000
2Estrogen Receptor betaIBA
10/2001 - 12/2000
2RNA (Ribonucleic Acid)IBA
09/2001 - 07/2000
2Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
05/2001 - 02/2001
2ElectrolytesIBA
04/2001 - 04/2000
2Prostate-Specific Antigen (Semenogelase)IBA
03/2001 - 12/2000
2Peroxynitrous Acid (Peroxynitrite)IBA
12/2000 - 01/2000
1Annexin A5IBA
03/2018
1Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
03/2018
1CaspasesIBA
03/2018
1Propidium (Propidium Iodide)IBA
03/2018
1src-Family KinasesIBA
03/2018
1bosutinibIBA
03/2018
1Caspase 3 (Caspase-3)IBA
03/2018
1Antigen-Antibody Complex (Immune Complex)IBA
02/2017
1Microphthalmia-Associated Transcription FactorIBA
12/2016
1Adenosine Monophosphate (AMP)IBA
12/2016
1Aromatase InhibitorsIBA
12/2014
1Sulfates (Sulfates, Inorganic)IBA
08/2014
1Cyclic AMP-Dependent Protein Kinases (cAMP-Dependent Protein Kinase)IBA
08/2014
1Organic Anion TransportersIBA
08/2014
1ColforsinIBA
08/2014
1SteroidsIBA
08/2014
1Sulfate TransportersIBA
08/2014

Therapy/Procedure

9Therapeutics
12/2012 - 10/2000
6Thyroidectomy
04/2006 - 04/2000
4Neoadjuvant Therapy
01/2014 - 04/2001
3Drug Therapy (Chemotherapy)
12/2012 - 01/2000
2Aftercare (After-Treatment)
12/2014 - 04/2014
2Neck Dissection (Radical Neck Dissection)
01/2005 - 10/2000
2Chemoprevention
11/2003 - 08/2000
2Lymph Node Excision (Lymph Node Dissection)
08/2002 - 06/2001
1Oncolytic Virotherapy
06/2018